DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

Intelligent data analytics software solution comes to electrophysiology with launch of Biosense Webster's CARTONET

RIA Endovascular Clinic opens first interventional suite in Denver metro area

Data suggests new guidelines in stroke care have led to record numbers of patients treated

Gore receives FDA approval for the GORE TAG conformable thoracic stent graft with ACTIVE CONTROL

Machine learning overtakes humans in predicting death or heart attack

Pulsara platform part of Duke Clinical Research Institute (DCRI) IMPROVE Stroke Care Project

Optimizing device implantation in patients with atrial fibrillation and risk of stroke

Miami Cardiac & Vascular Institute implements Philips MR technology

FDA grants first ever clearance for six-lead personal ECG device

Balt USA announces CE mark obtained for Titan aspiration catheter

Insera earns CE Mark approval for cyclical-suction stroke thrombectomy platform, the CLEAR aspiration system

Press releases may be edited for formatting or style
SACRAMENTO, Calif.--(BUSINESS WIRE)--Insera Therapeutics, Inc. announced today that it has received Conformité Européenne (CE) Mark approval for its flagship product, the CLEAR Aspiration System, for the aspiration of blood clots, and is indicated for use in patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease, secondary to cerebral venous sinus thrombosis, and optionally for staged aspiration through a balloon guide or guide catheter within the neck arteries.

This unique aspiration technology offers the ability to vary the vacuum suction pressures and intervals within the safe vacuum suction range up to -98.2 kPa (-29 inHg). A recent study using the CLEAR Aspiration System1 showed that complete clot ingestion with cyclical aspiration (namely varying the suction pressures) increases first-pass recanalization (namely ability to achieve full vessel re-opening using a single retrieval attempt) and reduces clot fragmentation compared to static aspiration (namely uniform suction pressure).

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



Approval was based on mechanical bench tests, safety and efficacy tests conducted in premier stroke device testing centers including: Intertek Electrical based out of Menlo Park, CA, Mayo Clinic in Rochester, MN, New England Center for Stroke Research (NECStR) in Worcester, MA, and The Jacobs Institute in Buffalo, NY.

The catheterizations in Buffalo, NY were performed by the Jacobs Institute’s Chief Medical Officer and SUNY at Buffalo Professor of Neurosurgery, Dr. Adnan Siddiqui, MD, PhD, FACS, FAHA, who noted, “The CLEAR Aspiration System includes a best-in-class, next-generation vacuum aspiration system that allows operators to employ uniform suction or cyclical suction patterns. The digital pump is powerful, easy-to-use, and can be operated remotely from an iPad, giving it an advantage over its competitors.”

The CLEAR Aspiration System has CE Mark approval for the aspiration of tissue and fluids in addition to blood clots, and is indicated for use in patients with hemorrhagic stroke or brain bleeds, for the controlled aspiration of tissue and/or fluid during surgery of the ventricular system or cerebrum, during neurosurgical, neuro-endoscopic, and other surgical procedures, including aspiration of tissue, fluids, tumor, and abscess.

The CLEAR Aspiration System also has European regulatory approval for the aspiration of foreign bodies in addition to blood clots, and is indicated for use for foreign body retrieval in the peripheral, neuro, and cardiovasculature, for the aspiration of blood clots from arteries (e.g. in patients with peripheral artery disease, pulmonary embolism, and coronary artery disease), and for the aspiration of blood clots from veins (e.g. in patients with deep venous thrombosis, or patients with renal failure who have clotted hemodialysis grafts).
  Pages: 1 - 2 >>

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED